WallStSmart

Sanmina Corporation (SANM)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sanmina Corporation generates 4280% more annual revenue ($11.34B vs $258.90M). SANM leads profitability with a 2.3% profit margin vs -15.5%. SANM earns a higher WallStSmart Score of 68/100 (B-).

SANM

Strong Buy

68

out of 100

Grade: B-

Growth: 8.0Profit: 5.5Value: 6.7Quality: 5.8
Piotroski: 4/9Altman Z: 1.87

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

SANMUndervalued (+18.9%)

Margin of Safety

+18.9%

Fair Value

$184.12

Current Price

$217.82

$33.70 discount

UndervaluedFair: $184.12Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SANM3 strengths · Avg: 8.7/10
Revenue GrowthGrowth
102.3%10/10

Revenue surging 102.3% year-over-year

PEG RatioValuation
0.978/10

Growing faster than its price suggests

EPS GrowthGrowth
46.6%8/10

Earnings expanding 46.6% YoY

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

SANM3 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.874/10

Grey zone — moderate risk

Profit MarginProfitability
2.3%3/10

2.3% margin — thin

P/E RatioValuation
45.6x2/10

Premium valuation, high expectations priced in

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : SANM

The strongest argument for SANM centers on Revenue Growth, PEG Ratio, EPS Growth. Revenue growth of 102.3% demonstrates continued momentum. PEG of 0.97 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : SANM

The primary concerns for SANM are Altman Z-Score, Profit Margin, P/E Ratio. A P/E of 45.6x leaves little room for execution misses. Thin 2.3% margins leave little buffer for downturns.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

SANM is growing revenue faster at 102.3% — sustainability is the question.

Monitor ELECTRONIC COMPONENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SANM scores higher overall (68/100 vs 41/100) and 102.3% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Sanmina Corporation

TECHNOLOGY · ELECTRONIC COMPONENTS · USA

Sanmina Corporation offers integrated solutions for manufacturing, components, products and repair, logistics and after-sales services globally. The company is headquartered in San Jose, California.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?